Skip to main content
Back to RA Capital Management

RA Capital Management's Oncology Portfolio

Browse 8 Oncology companies funded by RA Capital Management. See funding amounts, founder contacts, and investment details.

Oncology Companies
8
Total Funding in Oncology
$844.5M

Oncology Portfolio Companies (8)

Export
BiotechnologyOncology

Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).

Marseille, France
October 2025
$122.4M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceOncologyProduct Research

Idrx is a clinical-stage biopharmaceutical that develops oncology-based precision therapies to treat cancer.

Cambridge, United States
August 2024
$120.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyOncologyTherapeutics

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

Seattle, United States
February 2024
$112.0M
Series B

Founder Contacts

19,000+ verified contacts

BioinformaticsBiometricsBiopharmaBiotechnologyOncology

Mariana Oncology is a biotechnology research industry.

Watertown, United States
September 2023
$175.0M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyLife ScienceOncologyTherapeutics

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Cambridge, United States
February 2026
$150.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalOncologyTherapeutics

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

Redwood City, United States
February 2026
$50.1M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareOncologyTherapeutics

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Waltham, United States
February 2026
$40.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsOncologyPersonal Health

Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.

South San Francisco, United States
November 2025
$75.0M
Corporate Round

Founder Contacts

19,000+ verified contacts

Explore RA Capital Management's Full Portfolio

View all companies funded by RA Capital Management across every industry and funding stage.

View Full RA Capital Management Portfolio